366 results
The World Health Organization recently endorsed the first malaria vaccine, but malaria prevention remains a difficult endeavor. DynaMed® Medical Writer Keri Sheehan, Ph.D., explores this new development in malaria prevention.
Molnupiravir is a new antiviral pill to treat COVID-19. Here’s what we know so far.
EBSCO Information Services is committed to providing comprehensive resources that support and reflect social acceptance, health knowledge and multicultural competence, including how we address health disparity and build equity in our health care products.
A new study on time-restricted eating (also known as intermittent fasting) enters the weight loss evidence ecosystem, but did the study investigators evaluate what they claim? The EBM Focus team at DynaMed investigates.
Daniel A. Ostrovsky, MD, FAAP, FACP, Topic Editor at DynaMed and Associate Professor at Duke University, shares what he’s learned about telehealth from being on both sides of virtual healthcare delivery.
Medical research platforms need to do more than just provide relevant information. They need to meet user expectations and make searching for resources easy and fast.
Another monoclonal antibody therapy for Alzheimer Dementia has been approved for use in the United States. Will lecanemab be the silver bullet we’ve been waiting for?
EBSCO Nursing and Allied Health Section Editor, Mary Woten, BS, BSN, shares a first-hand account of patient encounters that deeply impacted both her own life and those of the patients.
The new EBSCO Discovery Service Health™ (EDS) user interface marries the personalized search features of popular websites to medical library functionalities.
In April 2020, the DynaMed® EBM Focus team answered ten common clinical questions about COVID-19. Here is an updated list of questions physicians are asking now.